Ken Griffin Medtronic PLC Put Options Transaction History

Citadel Advisors LLC

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	SELL	$76.84 - $91.03 $760,716 - $901,197	-9,900 Reduced 1.24%	788,600 $71 Million
Q2 2024 Aug 14, 2024	SELL	$78.71 - $87.02 $116 Million - $128 Million	-1,469,100 Reduced 64.79%	798,500 $62.8 Million
Q1 2024 May 15, 2024	BUY	$82.84 - $88.09 $109 Million - $116 Million	1,317,300 Added 138.62%	2,267,600 $198 Million
Q4 2023 Feb 14, 2024	SELL	$69.43 - $83.43 $7.53 Million - $9.05 Million	-108,500 Reduced 10.25%	950,300 $78.3 Million
Q3 2023 Nov 14, 2023	SELL	$78.22 - $90.4 $7.6 Million - $8.79 Million	-97,200 Reduced 8.41%	1,058,800 $83 Million
Q2 2023 Aug 14, 2023	SELL	$79.47 - $91.38 $84.2 Million - $96.8 Million	-1,059,800 Reduced 47.83%	1,156,000 $102 Million
Q1 2023 May 15, 2023	BUY	$76.72 - $87.58 $55.5 Million - $63.3 Million	723,100 Added 48.44%	2,215,800 $179 Million
Q4 2022 Feb 14, 2023	BUY	$76.18 - $87.74 $32.6 Million - $37.6 Million	428,000 Added 40.2%	1,492,700 $116 Million
Q3 2022 Nov 14, 2022	BUY	$80.75 - $95.31 $14.8 Million - $17.5 Million	183,600 Added 20.84%	1,064,700 $86 Million

2,283

1.02B

8.05M

7.19M

Ticker MDT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,329,149,952
Market Cap $112B
Description
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.